← Leaderboards

Taofeek K Owonikoko

Emory University

Google Scholar ↗PubMed ↗ORCID ↗

$3,956,887

Attributed

$4,172,718

Total exposure

6

Grants

5

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.9M · FY2011–25

$5M$3.8M$2.5M$1.3M$0

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$12,275,151 · 7

By mechanism

P30$9,284,322 · 3

R01$1,896,592 · 1

K23$815,448 · 1

UM1$224,789 · 1

K12$54,000 · 1

Top collaborators

Most similar at Emory University

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsUniversitiesResearch PersonnelClinical ResearchProgramsClinical TrialsFutureCancer CenterCancer PatientStructureFundingTrainingInnovationTranslational ResearchMarylandLaboratoriesComprehensive Cancer CenterDesignGrantMolecularClinical CareCollaborationsGenomicsImage

Grant awards (24)

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANT$2,317,500

P30 · FY2025 · CA · contact PI

Targeting polo-like kinase 1 (PLK1) for treatment of small cell lung cancer$648,269

R01 · FY2025 · CA · contact PI

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANT$249,999

P30 · FY2025 · CA · contact PI

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANT$249,968

P30 · FY2025 · CA · contact PI

Neighborhoods, Stress and Cancer Outcomes Across the Cancer Control Continuum: Leveraging ecological theory and geospatial analytics to improve cancer prevention and outcomes (Project LEGO)$149,999

P30 · FY2025 · CA · contact PI

Developmental Funds$128,751

P30 · FY2025 · CA · contact PI

Leadership, Planning and Evaluation$128,751

P30 · FY2025 · CA · contact PI

Advancing Oncologic Research Communities in Health Equity (ARCH) K12 Program$54,000

K12 · FY2025 · CA · contact PI

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANT$2,317,500

P30 · FY2024 · CA · contact PI

Developmental Funds$566,429

P30 · FY2024 · CA · contact PI

Leadership, Planning and Evaluation$357,958

P30 · FY2024 · CA · contact PI

Tumor-associated pDC (TApDC) and HIV infection in programing tumor microenvironment$249,999

P30 · FY2024 · CA · contact PI

Targeting CD38 in HIV-associated Lymphoma$249,968

P30 · FY2024 · CA · contact PI

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANT$2,317,500

P30 · FY2023 · CA · contact PI

Targeting polo-like kinase 1 (PLK1) for treatment of small cell lung cancer$545,942

R01 · FY2023 · CA · contact PI

Targeting polo-like kinase for therapy of small cell lung cancer$71,915

R01 · FY2023 · CA · contact PI

Targeting polo-like kinase for therapy of small cell lung cancer$630,466

R01 · FY2022 · CA · contact PI

The Johns Hopkins Translational Science Team for the ET-CTN$125,000

UM1 · FY2021 · CA

The Johns Hopkins Translational Science Team for the ET-CTN$99,789

UM1 · FY2021 · CA

Novel systemic therapy to improve clinical outcome in small cell lung cancer$162,667

K23 · FY2015 · CA · contact PI

Novel systemic therapy to improve clinical outcome in small cell lung cancer$162,853

K23 · FY2014 · CA · contact PI

Novel systemic therapy to improve clinical outcome in small cell lung cancer$163,078

K23 · FY2013 · CA · contact PI

Novel systemic therapy to improve clinical outcome in small cell lung cancer$163,298

K23 · FY2012 · CA · contact PI

Novel systemic therapy to improve clinical outcome in small cell lung cancer$163,552

K23 · FY2011 · CA · contact PI